Literature DB >> 12501971

Composite somatotroph--ACTH-immunoreactive pituitary adenoma with transformation of hyperplasia to adenoma.

N Mazarakis1, G Kontogeorgos, K Kovacs, E Horvath, N Borboli, G Piaditis.   

Abstract

The majority of pituitary adenomas are solitary and monohormonal, producing only one hormone. Double or multiple adenomas are rare. Plurihormonal adenomas may be monomorphous consisting of one cell type producing more than one hormones or plurimorphous composed of two or more distinct cell populations each producing different hormones. Primary pituitary hyperplasia is uncommon and transformation to adenoma has rarely been documented. We describe a unique case of somatotroph adenoma combined with ACTH-immunoreactive cell hyperplasia and focal transformation to adenoma. The 53-yr-old man was presented with a 2-yr history of headaches, enlargement of the hands and feet and coarsening of facial features. His blood GH was 17.5 ng/ml and he had absence of GH suppressional oral glucose tolerance testing. MRI demonstrated a mass with maximum diameter of 1.5 cm, on the left side of the pituitary, without invasion of surrounding tissues. Transsphenoidal surgery was performed. Morphology disclosed a mostly chromophobic tumor, immunoreactive for GH with ultrastructural characteristics of sparsely granulated somatotroph adenoma. The adenoma cell population was focally admixed with hyperplastic PAS positive and ACTH immunoreactive cells showing the electron microscopic features characteristic of corticotrophs. In these areas the acini were enlarged with distorted architecture of the reticulin pattern. Dissolution of the reticulin fiber network and transformation of hyperplastic ACTH-immunoreactive cells to adenoma was evident in small areas. The hyperplastic and adenomatous ACTH-immunoreactive cells were admixed with somatotroph adenoma cells. Due to lack of biochemically obvious cortisol hypersecretion, this ACTH-immunoreactive adenoma was classified as silent "corticotroph" subtype 1. This is an unusual case of composite pituitary adenoma consisting of somatotroph cells and hyperplastic ACTH-immunoreactive cells transforming to a frank adenoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12501971     DOI: 10.1023/a:1020764013137

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  22 in total

1.  Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis.

Authors:  H M Schulte; E H Oldfield; B Allolio; D A Katz; R A Berkman; I U Ali
Journal:  J Clin Endocrinol Metab       Date:  1991-12       Impact factor: 5.958

2.  Alpha-subunit immunoreactivity in plurihormonal pituitary adenomas of patients with acromegaly.

Authors:  G Kontogeorgos; K Kovacs; B W Scheithauer; D Rologis; G Orphanidis
Journal:  Mod Pathol       Date:  1991-03       Impact factor: 7.842

3.  Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.

Authors:  R G Gheri; W Boddi; F Ammannati; J Olivotto; C Nozzoli; A Franchi; L Bordi; M L Luisi; P Mennonna
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

4.  Clonal origin of pituitary adenomas.

Authors:  L B Jacoby; E T Hedley-Whyte; K Pulaski; B R Seizinger; R L Martuza
Journal:  J Neurosurg       Date:  1990-11       Impact factor: 5.115

Review 5.  Pituitary hyperplasia.

Authors:  E Horvath; K Kovacs; B W Scheithauer
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

6.  Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study.

Authors:  R M Carey; S K Varma; C R Drake; M O Thorner; K Kovacs; J Rivier; W Vale
Journal:  N Engl J Med       Date:  1984-07-05       Impact factor: 91.245

7.  Cushing's syndrome associated with ectopic production of corticotrophin-releasing hormone, corticotrophin and vasopressin by a phaeochromocytoma.

Authors:  T O'Brien; W F Young; D G Davila; B W Scheithauer; K Kovacs; E Horvath; W Vale; J A van Heerden
Journal:  Clin Endocrinol (Oxf)       Date:  1992-11       Impact factor: 3.478

8.  Pituitary-directed leukemia inhibitory factor transgene causes Cushing's syndrome: neuro-immune-endocrine modulation of pituitary development.

Authors:  H Yano; C Readhead; M Nakashima; S G Ren; S Melmed
Journal:  Mol Endocrinol       Date:  1998-11

9.  Clinically nonfunctioning pituitary tumors are monoclonal in origin.

Authors:  J M Alexander; B M Biller; H Bikkal; N T Zervas; A Arnold; A Klibanski
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

10.  Clonal origin of pituitary adenomas.

Authors:  V Herman; J Fagin; R Gonsky; K Kovacs; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

View more
  9 in total

1.  Double adenomas of the pituitary: transcription factors Pit-1, T-pit, and SF-1 identify cytogenesis and differentiation.

Authors:  R A Jastania; K O Alsaad; M Al-Shraim; K Kovacs; S L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Lycopene ameliorates atrazine-induced oxidative damage in adrenal cortex of male rats by activation of the Nrf2/HO-1 pathway.

Authors:  Marwa Ahmed Abass; Shereen Ahmed Elkhateeb; Samia Adel Abd El-Baset; Asmaa Alhosiny Kattaia; Eman Mosallam Mohamed; Hebatallah Husseini Atteia
Journal:  Environ Sci Pollut Res Int       Date:  2016-04-22       Impact factor: 4.223

3.  The pituitary in klinefelter syndrome.

Authors:  B W Scheithauer; M Moschopulos; K Kovacs; B S Jhaveri; T Percek; R V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

4.  Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1.

Authors:  E Ferretti; D Di Stefano; F Zazzeroni; R Gallo; A Fratticci; R Carfagnini; S Angiulli; A Santoro; G Minniti; G Tamburrano; E Alesse; G Cantore; A Gulino; M L Jaffrain-Rea
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

5.  Immunohistochemical properties of silent corticotroph adenoma and Cushing's disease.

Authors:  Kazumi Iino; Yutaka Oki; Fumie Matsushita; Miho Yamashita; Chiga Hayashi; Katsutoshi Miura; Shigeru Nishizawa; Hirotoshi Nakamura
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 6.  Multiple Pituitary Adenomas: A Systematic Review.

Authors:  Renata M Budan; Carmen E Georgescu
Journal:  Front Endocrinol (Lausanne)       Date:  2016-02-01       Impact factor: 5.555

7.  A rare corticotroph-secreting tumor with coexisting prolactin and growth hormone staining cells.

Authors:  Subramanian Kannan; Susan M Staugaitis; Robert J Weil; Betul Hatipoglu
Journal:  Case Rep Endocrinol       Date:  2012-12-17

8.  Multihormonal pituitary adenoma concomitant with Pit-1 and Tpit lineage cells causing acromegaly associated with subclinical Cushing's disease: a case report.

Authors:  Tomoko Takiguchi; Hisashi Koide; Hidekazu Nagano; Akitoshi Nakayama; Masanori Fujimoto; Ai Tamura; Eri Komai; Akina Shiga; Takashi Kono; Seiichiro Higuchi; Ikki Sakuma; Naoko Hashimoto; Sawako Suzuki; Yui Miyabayashi; Norio Ishiwatari; Kentaro Horiguchi; Yukio Nakatani; Koutaro Yokote; Tomoaki Tanaka
Journal:  BMC Endocr Disord       Date:  2017-09-02       Impact factor: 2.763

9.  Cushing's Syndrome in a Patient With Rathke's Cleft Cyst and ACTH Cell Hyperplasia Detected by 11C-Methionine PET Imaging-A Case Presentation.

Authors:  Karol Piotr Sagan; Elzbieta Andrysiak-Mamos; Leszek Sagan; Przemysław Nowacki; Bogdan Małkowski; Anhelli Syrenicz
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-22       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.